This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 14 Nov 2016  |  Asia Pacific  |  Market Research

    Analysis of the Indonesian Clinical Laboratories Market

    Increase in Test Volumes Due to Universal Health Coverage will Boost Market Growth Across All Segments

    Given the ever-increasing cost of care, healthcare delivery is moving towards decentralisation. Service delivery from health settings such as mobile clinics, rapid retail clinics, and home settings demands the use of new-age clinic laboratory diagnostics. Effective delivery of healthcare services has created a business and technology convergence be...

    $1,500.00
  2. 11 Nov 2016  |  Asia Pacific  |  Market Research

    Analysis of the Australian Clinical Laboratory Market

    Evolving Business Model—Technological Advances will Drive the Market

    Given the ever increasing cost of care, healthcare delivery is moving towards decentralisation. Service delivery from healthcare settings such as mobile clinics, rapid retail clinics, and home settings demands the use of new-age clinical laboratory diagnostics. The effective delivery of healthcare services has created a business and technology conv...

    $1,500.00
  3. 15 Jul 2016  |  Europe  |  Market Research

    Snapshot of the Mobile Health (mHealth) Market Opportunity in Europe

    Sector Convergence is Generating Growth Opportunities Across the Value Chain

    Mobile Health (mHealth) can play a vital role in European healthcare systems by improving communication between providers and patients and enabling patients to participate more actively in their health and wellness. At both EU and country levels, various pilot projects have demonstrated positive outcomes—both qualitative and quantitative—result...

    $1,500.00
  4. 12 Jul 2016  |  Asia Pacific  |  Market Research

    Analysis of the APAC Health Information Exchange Market

     

    This research service analyzes the health information exchange (HIE) market in Asia-Pacific. Driven primarily by governments, the region is embarking on the next phase of healthcare IT transformation, investing in decentralizing patient information by enabling data exchange among established electronic medical record (EMR) and electronic health rec...

    $4,950.00
  5. 01 Jul 2016  |  Europe  |  Market Research

    Western Europe Point-of-Care Testing (POCT) Market

    Point-of-care testing is an integral part of the IVD market that is rapidly evolving into a preferred testing mode in the EU region. POCT is a segment that presents growth opportunities for a cross-section of players, ranging from OEMs to data integrators to technology vendors. The stakeholders need to be abreast of the challenges posed by the indu...

    $4,950.00
  6. 24 Jun 2016  |  Europe  |  Market Research

    Business Analytics in Life Sciences

    The Time is Ripe for a Technology Revamp in Clinical Trials

    The drastic increase in the number of clinical trials performed worldwide is leading to a sharp rise in R&D expenditure incurred by life sciences companies. To overcome this challenge, companies are targeting clinical trials to achieve higher efficiencies, which will bring new drugs faster to market and reduce R&D cost burden. The solution lies in ...

    $3,000.00
  7. 31 May 2016  |  Asia Pacific  |  Market Research

    2016 Indonesia Transformational Health Insights

    Current Trends and Challenges Encountered in the Road to Achieving Universal Healthcare Coverage

    Indonesia is expected to see a substantial rise in healthcare spending driven by rapid urbanization, a growing middle class population, and an increasing prevalence of chronic diseases. Government initiatives to provide universal healthcare coverage (UHC) by 2019 are one of the key reasons for making Indonesia an attractive healthcare market. All t...

    $1,500.00
  8. 11 May 2016  |  Asia Pacific  |  Market Outlook

    Asia-Pacific Telehealth Market Outlook, Forecast to 2020

    Shifting Cost and Consumer Trends to Support Innovative Delivery Models Driven by mHealth, Remote Patient Monitoring and Telemedicine

    Healthcare industry challenges including aging populations, rising incidence of chronic diseases, and the need to manage care costs better are necessitating the adoption of innovative care delivery models. While healthcare providers and consumers are displaying a perceivable behavior shift in the way they interact with health technologies, vendors ...

    $4,950.00
  9. 06 May 2016  |  Asia Pacific  |  Market Research

    Global Generic Pharmaceuticals Market, Forecast to 2020

    Market Participants Target High Value-added Branded Generics and Biosimilars Segments

    The key objectives of this research service are to gain an in-depth knowledge of the major markets and therapeutic areas and organizations presenting significant growth opportunities for generics, to understand the impact of regulation on the market, and to outline the industry consolidation trends that will continue shaping the future of generics....

    $4,950.00
  10. 04 May 2016  |  Europe  |  Market Research

    European Autoimmune Diagnostics Market, Forecast to 2020

    Ageing Population and High Disease Prevalence to Trigger Growth, Localised Disease Segment Offers Revenue Potential

    The high prevalence of diseases in Europe is a market opportunities for the market participants, especially considering the ageing population in these regions. This leads to the need for better and early diagnosis. This market includes revenues from instruments and reagents. Market revenues and installed base (units) for the entire Western Europe, ...

    $1,500.00